Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07287943 · ClinicalTrials.gov registry record · NA
To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.
A NA study of Type 1 Diabetes and Gastroparesis Due to Diabetes Mellitus Type I, sponsored by Viral N. Shah.
- Recruiting
- Registry status
- NA
- Development phase
- 34
- Enrollment target
- 1
- Study location
NCT07287943 is a NA study of Type 1 Diabetes and Gastroparesis Due to Diabetes Mellitus Type I that is actively recruiting participants, run by Viral N. Shah. The registered enrollment target is 34 participants, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07287943, a NA study of Type 1 Diabetes and Gastroparesis Due to Diabetes Mellitus Type I, is actively recruiting participants, sponsored by Viral N. Shah.
- RECRUITING
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to evaluate the efficacy and safety of Medtronic 780G automated insulin delivery system in adult persons with type 1 diabetes and gastroparesis.
Conditions Studied
Interventions
- DEVICE Medtronic 780G AID
Study Locations (1)
Indiana
- Indiana University Health, Univeristy hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2026-02-09 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07287943
The ClinicalTrials.gov registry entry for NCT07287943 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (96% lower). The listed sponsor is Viral N. Shah, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Type 1 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Medtronic 780G AID is the first listed.
NCT07287943 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT07287943 about?
NCT07287943 is a clinical study titled "To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.". The goal of this clinical trial is to evaluate the efficacy and safety of Medtronic 780G automated insulin delivery system in adult persons with type 1 diabetes and gastroparesis.
What is the current status of trial NCT07287943?
This trial is currently recruiting. It is a NA study. The enrollment target is 34 participants. The study started on 2026-02-09. Estimated completion is 2026-12-01.
What conditions does trial NCT07287943 study?
This clinical trial studies the following conditions: Type 1 Diabetes, Gastroparesis Due to Diabetes Mellitus Type I.
What interventions are being tested in trial NCT07287943?
The interventions under investigation include: Medtronic 780G AID (DEVICE).
Who is sponsoring clinical trial NCT07287943?
This trial is sponsored by Viral N. Shah, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07287943 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
REAL-Fam Feasibility Study for Youth Diabetes Management
RECRUITING · NA
-
AIDANET Pediatrics
RECRUITING · NA
-
A Study Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects With Type 1 Diabetes
RECRUITING · NA
-
Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 Diabetes Using Automated Insulin Delivery
RECRUITING · NA
-
EMPoWER Study - Strengths-based Behavioral Intervention for Youth With Type 1 Diabetes
RECRUITING · NA
-
Safety and Feasibility of a Machine-Learning Bolus Priming Added to Existing Control Algorithm
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.